4Cyte vs Antinol for Dogs: What the Dog Trials Show

What's in each one

Start with what’s in the tub, because both brands sell more than one product and the differences get blurred. The 4Cyte gel most people buy is Epiitalis Forte: Epiitalis, a patented oil drawn from Biota orientalis seed, carried in soybean oil with rosemary extract. It’s deliberately marine-free. The brand's separate 4Cyte Canine granules are a different formulation that does include marine ingredients, so the two aren’t interchangeable. The pitch for both is cartilage support, so the brand talks about working on the joint surface over time. Don't expect a quick hit of comfort from it.

Antinol Plus is built on EAB-277, which pairs green-lipped mussel (Perna canaliculus) lipid extract with high-phospholipid krill oil. Its documented action is on the enzyme pathways that drive joint inflammation, and that's a different thing from loading a dog up with omega-3. The distinction changes what the capsule can stand in for. Mussel and krill are both shellfish. If your dog has reacted to a marine ingredient before, that rules Antinol out and makes the marine-free 4Cyte gel the option to look at.

Why target inflammation at all? Inside a worn joint it feeds on itself. The swelling that brings on pain also speeds up the damage that brings on more swelling. Break into that loop and a dog that has been favouring a leg will often start trusting it again. 4Cyte comes at the same joint from the cartilage side instead, which is why the brand talks up cartilage support.

What the dog trials found

Both actives have been put in front of real dogs, which is uncommon on this shelf. But the trials aren’t equivalent, and the differences matter more than the headlines.

The trial that tested both. In 2024, a blinded, placebo-controlled study put 101 dogs with hip osteoarthritis into four groups: Antinol Rapid (the EAB-277 blend), 4CYTE Epiitalis Forte, the NSAID meloxicam, and a placebo. It measured peak vertical force — a force-plate reading of how much weight a dog will put through a sore leg. At six weeks, the EAB-277 and meloxicam groups had improved significantly more than both the placebo and the 4CYTE groups, and the placebo and 4CYTE groups weren’t different from each other. The authors' conclusion was that meloxicam and EAB-277 showed measurable benefit over placebo, and 4CYTE didn’t.

That’s the single most relevant study for anyone choosing between these two, so read it with its limits in view. It was funded by Pharmalink International, which makes Antinol. Industry funding doesn’t make a blinded, placebo-controlled trial wrong, and this one used the actual retail formulations. But it does mean a result favouring the funder's product deserves independent replication before anyone treats it as settled, and that hasn't happened yet.

4Cyte's carprofen trial, and what it doesn’t show. The result the brand is best known for came from a 2021 study where dogs with osteoarthritis were given either 4CYTE Canine granules or carprofen, and the granules came out non-inferior to carprofen out to day 28. Two things to note. It tested the granules. The gel is a different formulation. And it had no placebo arm — only two groups — so matching carprofen in that design can't show that either treatment did more than time and attention would have. That’s the caveat that carries the most weight, and it’s usually the one left out.

Antinol's earlier evidence. A separate double-blind trial compared the mussel-lipid compound against glucosamine and chondroitin and against carprofen, and measured limb loading the same way. The mussel-oil group's loading rose to a level comparable with carprofen at four and six weeks, while the glucosamine and chondroitin group didn’t shift. Worth knowing in the same breath: the subjective orthopaedic scores in that trial didn’t change significantly in any group, carprofen included. Only the force plate moved. If you’re planning to judge either product by what you can see over a month, that’s a useful reminder of how hard it’s to eyeball.

What none of this shows is a cure. Neither oil turns back arthritis or regrows cartilage that has already gone, and neither stands in for a diagnosis. If you want the longer look at the gel on its own, we go deeper in our guide to what 4Cyte does and whether it’s worth it.

Gel or capsule, and what it costs to keep up

The day-to-day matters, because a dose skipped is a dose that does nothing. 4Cyte's gel suits a lot of dogs — a palatable squeeze off a spoon, no capsule to bury and no powder to stir through. Antinol's softgel is small and tucks into food, which suits a dog who treats anything gel-like with suspicion, and capsules travel better if you need to portion doses ahead.

On cost the gap is wide, and it runs the opposite way to what "two premium names" suggests. The 4Cyte gel is one of the more affordable joint supplements we cover — cheaper per day than the glucosamine chews it sits beside. Antinol runs to roughly four times the daily spend, because the maintenance dose for a mid-sized dog is two capsules. Both are long-term commitments: the effect fades whenever the daily dose lapses.

Does Antinol do a second job on skin and coat?

The brand positions Antinol as joint, skin and coat support, and it’s worth unpacking before you take it at face value. The mussel and krill lipids do contain EPA and DHA, the omega-3s associated with skin barrier health. But the amounts per capsule are small next to a dedicated fish oil, and the compound's documented action on the joint works through enzyme pathways.

If your dog needs omega-3 for its skin, buy an omega-3 for its skin. Antinol isn’t a substitute for one, and it’s not priced like one.

So treat any skin and coat benefit as a possible bonus. It isn't a reason to drop a fish oil your vet has recommended. That also undercuts the usual argument for Antinol's price — that one product covering two jobs beats buying two. On these doses it doesn’t reliably cover the second job, so the premium is better justified by the placebo-controlled joint result than by breadth.

Which one suits your dog

We aren’t naming a winner, because the two things you would weigh point in different directions. Here’s how we’d weigh it.

Lean to Antinol if the placebo-controlled evidence is what you care most about, and your dog has no history of reacting to shellfish. It’s the one of the two with a blinded, placebo-controlled result in its favour, and that’s not nothing — just remember who paid for it, and that it hasn’t been independently replicated.

Lean to 4Cyte's gel if your dog has reacted to marine ingredients before, in which case the marine-free formulation is the only one of the two that’s suitable. It’s also the far lower monthly spend, and the easier format for a dog who won’t take a capsule. Go in knowing the gel itself didn’t separate from placebo in the one trial that tested it that way.

Consider neither yet if the stiffness is new, getting worse quickly, or you haven’t had it looked at. A supplement is the last thing you add to a joint plan, once the diagnosis and the weight are sorted.

Whichever way you lean, the biggest win doesn’t come in a tub or a capsule. Extra weight loads a sore joint with every single step, so trimming a round dog back to a lean frame often buys more comfort than any oil will. If you aren’t sure what that looks like on the scales, our guide to feeding for your dog's ideal weight is where to start. And for the wider field, including the picks that beat both of these on our own scoring, see best joint supplements for dogs in Australia.

Both of these are doing something more considered than most of the aisle, and both have been tested in living dogs, well past the lab-dish stage. Read the evidence for what it’s, match the formulation to your dog — especially on shellfish — give it a fair run, and keep your vet in the loop, above all if the stiffness is new or worsening.